Skip to main content

Call for Abstracts



Submit an Abstract


The National Foundation for Infectious Diseases (NFID) invites abstract submissions of original research for presentation at the virtual 2021 Annual Conference on Vaccinology Research (ACVR). Abstracts are peer-reviewed for quality of research, educational and scientific content, and overall impact. Accepted abstracts will be scheduled as oral or poster presentations at the conference scheduled for April 26-27, 2021.

Questions? Email:

5 Easy Steps to Submit:

1. Read the instructions below
2. Concisely summarize research background, methods, and results/conclusions, and include at least one reference
3. Complete presenter information and Conflicts of Interest (COI) disclosures
4. List abstract authors
5. Submit


March 1, 2021                     Abstract submission deadline (11:59 PM ET) (extended)
March 31, 2021                   Notifications issued for all submitted abstracts
April 26-27, 2021                Virtual 2021 Annual Conference on Vaccinology Research (ACVR)

How to Submit:

All abstracts must be submitted electronically through the ACVR online submission site ( Abstracts submitted by email, fax, or mail will not be accepted. Incomplete abstracts will not be reviewed.

After initiating your abstract submission, you will be given a link to complete and submit your abstract. You will also receive an email with the link. You may begin the submission process and return to saved proposals using the link at any time up until the submission deadline.

Topics for Abstract Submission:
The submitting author must select the most appropriate topic from the list below. The ACVR Planning Committee reserves the right to change the topic of accepted abstracts.

  • Behavioral Science and Vaccine Hesitancy
  • Epidemiology and Burden of Vaccine-Preventable Diseases
  • Vaccine Policy, Regulatory Pathways, Programs, and Practice
  • Vaccine Research, Development, and Production
  • Vaccine Safety, Monitoring, and Evaluation
  • Vaccines Against Emerging and Re-Emerging Infectious Diseases
  • Vaccines to Combat Antimicrobial Resistance

Abstract Format:
All abstracts must be submitted in English and must reflect original work. Abstracts based on prior presentations with updated information and additional data generated and/or analyzed are permitted.

Abstracts must contain the following components:

  • Abstract Title: (200 character limit) a concise title that summarizes the content
  • Abstract Takeaway: (170 character limit) 1-2 sentence description of your key research findings; what you want the learner to remember from your presentation
  • Background: (150 word limit) a concise statement of the issue under investigation or a hypothesis
  • Methods: (200 word limit) the experimental methods used (including the statistical analyses employed)
  • Results & Conclusions: (250 word limit) a summary of specific findings and results (statistical analyses used to support the conclusions should be included; concluding statements such as “the results will be discussed” or “to be completed” are not acceptable)
  • References: at least one literature reference/citation to support your research data (multiple references are strongly recommended; ten maximum). Use the conventional style for listing references as referred by the American Medical Association (AMA) Manual of Style: A Guide for Authors and Editors. Sample references are available at:
  • Author(s): (limit of 10 authors) Submittals must identify full contact information for the Presenting Author (individual who will be presenting the research at the conference if accepted). All authors must be listed in the order in which they should appear in the program materials if accepted.

It is the responsibility of the submitter to ensure that all information submitted is correct. Any errors in spelling, grammar, or scientific facts may be published as submitted.

Figures and tables are not accepted with abstract submissions.

All abstract submissions will be reviewed by members of the ACVR Planning Committee for scientific merit and relevance to the field of vaccinology. Abstract submissions are reviewed for the following: a clearly stated hypothesis or issue; experimental and statistical methods used; specific findings (statements such as “the data will be presented” are unacceptable); and specific conclusions (statements such as “the results will be discussed” are unacceptable). Authors of accepted abstracts will be invited to present their work in a 10-minute oral presentation or a poster.

Presenter Information:
Detailed information for preparing presentations will be provided upon abstract acceptance.

Registration & Attendance:
All abstract presenters must register for the conference and pay the appropriate registration fee in order to present their abstract. Each presenter may present only one abstract. Presenters who fail to appear at the conference at the specified time(s) will forfeit their registration fee and future abstract submissions may be automatically disqualified from consideration. NFID does not provide any support for registration fees.

Abstract Publication:
All abstracts will be published in conference program materials. Select presentations may be included in future publications with author permission.